Major involvement of rabbit liver cytochrome P4501A in thiabendazole 5-hydroxylation

References

• Aix L., Rey-Grobellet X., Larrieu G., Lesca P., Galtier P. Thiabendazole is an inducer of cytochrome P4501A1 in cultured rabbit hepatocytes. Biochemical and Biophysical Research Communications 1994; 202: 1483–1489
   PubMed Web of Science ®Google Scholar
• Alvinerie M., Sutra J. F., Galtier P. Dosage par CLHP de deux médicaments à caractére basique (triméthoprime, thiabendazole) à l'aide d'une phase greffée avec désactivation des silanols libres. Analusis 1991; 19: 244–248
   Google Scholar
• Bauer L. A., Raisys V. A., Watts M. T., Ballinger J. The pharmacokinetics of thiabendazole and its metabolites in an anephric patient undergoing hemodialysis and hemo-perfusion. Journal of Clinical Pharmacology 1982; 22: 276–280
   PubMedGoogle Scholar
• Cochin J., Axelrod J. Biochemical and pharmacological changes in the rat following chronic administration of morphine, nalorphine and normorphine. Journal of Pharmacology and Experimental Therapeutics 1959; 125: 105–115
   PubMed Web of Science ®Google Scholar
• Coon M. J., Van Der Hoeven T. A., Dahl S. B., Haugen D. A. Two forms of liver microsomal cytochrome P450, P450LM2 and P450LM4 (rabbit liver). Methods in Enzymology 1978; 52: 109–117
   PubMedGoogle Scholar
• Dalet Beluche I., Boulenc X., Fabre G., Maurel P., Bonfils C. Purification of two cytochrome P450 isoenzymes related to CYP2A and CYP3A gene families from monkey liver microsomes. European Journal of Biochemistry 1992; 204: 641–648
   PubMedGoogle Scholar
• Daujat M., Pichard L., Fabre I., Pineau T., Fabre G., Bonfils C., Maurel P. Induction protocols for cytochrome P450IIIA in vivo and in primary cultures of animal and human hepatocytes. Methods in Enzymology 1991; 206: 345–353
   PubMed Web of Science ®Google Scholar
• Franz K. H. Clinical trials with thiabendazole against human strongyloidiasis. American Journal of Tropical Medicine and Hygiene 1963; 12: 211–214
   Web of Science ®Google Scholar
• Fujitani T., Yoneyama M., Ogata A., Ueta T., Mori K., Ichikawa H. New metabolites of thiabendazole and the metabolism of thiabenazole by mouse embryo in vivo and in vitro. Food and Chemical Toxicology 1991; 29: 265–274
   PubMedGoogle Scholar
• Gonzalez F. J. Human cytochromes P450, Problems and prospects. Trends in Pharmacological Sciences 1992; 13: 346–352
   PubMed Web of Science ®Google Scholar
• Halpert J. R., Guengerich F. P., Bend J. R., Correia M. A. Selective inhibitors of cytochromes P450. Toxicology and Applied Pharmacology 1994; 125: 163–175
   PubMed Web of Science ®Google Scholar
• Kikuta Y, Kusunose E., Okumoto T., Kubota I., Kusunose M. Purification and characterization of two forms of cytcchrome P450 with omega-hydroxylase activities towards prostaglandin A and fatty acids from rabbit liver microsomes. Journal of Biochemistry 1990; 107: 280–286
   PubMed Web of Science ®Google Scholar
• Kuo P. C., Abe K. Y. Cytokine-mediated production of nitric oxide in isolated rat hepatocytes is dependent on cytochrome P450III activity. FEBS Letters 1995; 360: 10–14
   PubMedGoogle Scholar
• Lake B. J. Preparation and characterisation of microsomal fraction for studies on xenobiotic metabolism. Biochemical Toxicology, K. Snell, B. Mullock. ICR, Oxford 1987; 183–215
   Google Scholar
• Lowry O. H., Rosebrough W. J., Farr A. L., Randall R. J. Protein measurement with Folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Lubet R. A., Mayer R. T., Cameron J. W., Nims R. W., Burke M. D., Woff T., Guengerich F. P. Dealkylation of pentoxyresorufin: a rapid and sensitive assay for measuring induction of cytochrome(s) P450 by phenobarbital and other xenobiotics in the rat. Archives of Biochemistry and Biophysics 1985; 238: 43–48
   PubMed Web of Science ®Google Scholar
• MacKellar Q. A., Scott E. W. The benzimidazole anthelminthic agents, a review. Journal of Veterinary Pharmacology and Therapeutics 1990; 13: 223–247
   PubMedGoogle Scholar
• Mizutani T., Ito K., Nomura H., Nakanishi K. Nephrotoxicity of thiabendazole in mice depleted of glutathione by treatment with DL-buthionine sulphoximine. Food and Chemical Toxicology 1990; 28: 169–177
   PubMed Web of Science ®Google Scholar
• Mizutani T., Yoshida K., Ito K. Nephrotoxicity of thiazoles structurally related to thiabendazole in mice depleted of glutathione by treatment with buthionine sulfoximine. Research Communications in Chemical and Pathological Pharmacology 1992; 75: 29–38
   PubMedGoogle Scholar
• Salaün J. P., Simon A., Durst F. Specific induction of lauric acid ω-hydroxylase by clofibrate, diethylhexyl-phtalate and 2,4-dichlorophenoxyacetic acid in higher plants. Lipids 1986; 21: 776–779
   Google Scholar
• Stone O. J., Mullins J. F., Willis C. J. Comparison of thiabendazole and 5 hydroxy-thiabendazole. Journal of Investigations in Dermatology 1965; 45: 132–133
   PubMed Web of Science ®Google Scholar
• Tocco D. J., Egerton J. R., Bowers W., Christensen V. W., Rosenblum C. Absorption, metabolism and elimination of thiabendazole in farm animals and a method for its estimation in biological materials. Journal of Pharmacological and Experimental Therapeutics 1965; 149: 263–271
   PubMed Web of Science ®Google Scholar
• Tocco D. J., Rosenblum C., Martin C. M., Robinson H. J. Absorption, metabolism, and excretion of thiabendazole in man and laboratory animals. Toxicology and Applied Pharmacology 1966; 9: 31–39
   PubMed Web of Science ®Google Scholar
• Tocco D. J. The metabolic fate of thiabendazole in Sheep. Journal of Medicinal Chemistry 1964; 7: 399–405
   PubMed Web of Science ®Google Scholar
• Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of protein from polyacrylamide gels to nitrocellulose sheets, procedure and some applications. Proceedings of the National Academy of Sciences, USA 1979; 76: 4350–4354
   PubMed Web of Science ®Google Scholar
• Tsuchiya T., Tanaka A., Fukukoa M., Sato M., Yamaha T. Metabolism of thiabendazole and teratogenic potential of its metabolites in pregnant mice. Chemical and Pharmaceutical Bulletin 1987; 35: 2985–2993
   PubMedGoogle Scholar
• Wilson C. G., Parke D. V., Cawthorne M. A. Investigation of 5-hydroxylation of thiabendazole in rat liver microsomal preparations. Biochemical Society Transactions 1973; 1: 511–514
   Google Scholar
• Wilson C. G., Parke D. V., Green J., Cawthorne M. A. Inhibition of thiabendazole metabolism in the rat. Xenobiotica 1979; 9: 343–351
   PubMed Web of Science ®Google Scholar
• Yamaoka K., Tanigawara K., Nakagawa T., Uno T. A pharmacokinetic analysis program (MULTI) for microcomputer. Journal of Pharmacobiodynamic 1981; 4: 879–885
   PubMedGoogle Scholar
• Yoneyama M., Ichikawa H. Irreversible in vivo and in vitro binding of thiabendazole to tissue protein of pregnant mice. Food and Chemical Toxicology 1986; 24: 1823–1826
   Google Scholar